Understanding how common fibromyalgia is in adults in Al-Karak, Jordan
The Prevalence of Fibromyalgia in Adults at Al-Karak Jordan a Cross-sectional Study
This study is trying to find out how many adults in Al-Karak, Jordan have fibromyalgia to help improve healthcare in the area.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 965 (estimated) |
| Ages | 1 Month to 100 Years |
| Sex | All |
| Sponsor | Mutah University Academic / other |
| Locations | 1 site (Al-Karak) |
| Trial ID | NCT06103058 on ClinicalTrials.gov |
What this trial studies
This observational study aims to determine the prevalence of fibromyalgia among adults living in Al-Karak, Jordan. By utilizing a cross-sectional approach, the researchers will gather data through questionnaires distributed via social media, ensuring participant autonomy and ethical compliance. The study seeks to fill knowledge gaps regarding fibromyalgia's occurrence in this specific geographic area, which may have unique demographic and environmental influences. The findings will provide valuable insights for healthcare planning and resource allocation in the community.
Who should consider this trial
Good fit: Ideal candidates for this study are adults residing in Al-Karak, Jordan, who are willing to participate in a survey about fibromyalgia.
Not a fit: Patients outside of Al-Karak or those who do not have fibromyalgia may not receive any benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide crucial data to improve healthcare services and resources for individuals suffering from fibromyalgia in the region.
How similar studies have performed: While studies on fibromyalgia prevalence exist, this specific focus on Al-Karak may provide novel insights into the condition's local impact.
Eligibility criteria
Show full inclusion / exclusion criteria
Using google forms, this cross-sectional study was carried out, and the participants were reached via social media platforms (5) . Participants' autonomy was maintained, and no direct benefit was gained in return for filling out the questionnaire. The ethics committee at the Faculty of Medicine, Mutah University, Karak, Jordan, provided the required ethical approval prior to the initiation of this study. Moreover, the committee ensured that the study was designed according to the principles of the Declaration of Helsinki (Date: 13 February 2023. Reference number: 992023). In this study, the authors targeted Karak government citizens, in Jordan. Accordingly, the required sample size to achieve a 99% Confidence interval was 663 participants.
Where this trial is running
Al-Karak
- Mutah University — Al-Karak, Jordan (Recruiting)
Study contacts
- Study coordinator: Mohammad Abu-Jeyyab, MD
- Email: mabujeyyab@yahoo.com
- Phone: +962796383747
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.